Quick Answer
MARIMED INC. reported Cash and Equivalents of $7.28 million for fiscal year 2024.
MARIMED INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $7.28M | -50.3% |
| 2023 | $14.64M | +50.4% |
| 2022 | $9.74M | -67.2% |
| 2021 | $29.68M | +889.7% |
| 2020 | $3.00M | +306.0% |
| 2019 | $738.7K | -82.0% |
| 2018 | $4.10M | +218.1% |
| 2017 | $1.29M | +126.6% |
| 2016 | $569.4K | +253.9% |
| 2015 | $160.9K | -83.7% |
| 2014 | $988.3K | +11474.9% |
| 2013 | $8.5K | -0.5% |
| 2012 | $8.6K | -92.8% |
| 2011 | $118.8K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.60M | -32.6% | +7.5% |
| June 30, 2025 | $6.14M | -39.8% | -14.8% |
| March 31, 2025 | $7.20M | -52.7% | -1.1% |
| December 31, 2024 | $7.28M | -50.3% | -25.6% |
| September 30, 2024 | $9.79M | -26.2% | -4.0% |
| June 30, 2024 | $10.19M | -30.4% | -33.1% |
| March 31, 2024 | $15.23M | -29.5% | +4.0% |
| December 31, 2023 | $14.64M | +50.4% | +10.5% |
- MARIMED INC. showed a decrease of -50.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2011–2024 period, MARIMED INC.’s cash and equivalents has grown by 6029.5% (from $118.8 thousand to $7.28 million).
- The most recent figure is from MARIMED INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 6, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: